WINT: Gunggung utang perusahaan Windtree

Windtree Therapeutics (WINT) is a pharmaceutical player in the cardiology sector facing the threat of bankruptcy and a liquidity shortage. This daily price chart illustrates metrics where the value stands at 0.00. The company's operations rely on developing therapies for critical heart failure. Despite holding patents, a weak economic moat persists due to constant FDA rejections and a lack of research funding.

This metric aggregates the total of all bank loans and bond issues, reflecting the level of debt burden and the risk of insolvency amid asset volatility. For Windtree Therapeutics (WINT), which invests in proprietary cardiovascular drugs, an analysis of total borrowed funds confirms strict control over clinical trial expenditures, ensuring capital stability and protection against credit risks.